Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Goodwill & Intangibles (2023 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Goodwill & Intangibles for 3 consecutive years, with $142.1 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 28.53% to $142.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $142.1 million through Dec 2025, down 28.53% year-over-year, with the annual reading at $142.1 million for FY2025, 28.53% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $142.1 million at Cartesian Therapeutics, down from $198.8 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $198.8 million in Q4 2023, with the low at $142.1 million in Q4 2025.
  • Average Goodwill & Intangibles over 3 years is $192.5 million, with a median of $198.8 million recorded in 2023.
  • The sharpest move saw Goodwill & Intangibles changed 0.0% in 2024, then dropped 28.53% in 2025.
  • Over 3 years, Goodwill & Intangibles stood at $198.8 million in 2023, then changed by 0.0% to $198.8 million in 2024, then decreased by 28.53% to $142.1 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $142.1 million, $198.8 million, and $198.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.